Dexamethasone 1.5 mg is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is Dexamethasone.
| Product ID | 68047-702_7be555cd-132c-50b5-e053-2a91aa0a91e2 |
| NDC | 68047-702 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexamethasone 1.5 mg |
| Generic Name | Dexamethasone 1.5 Mg |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA201270 |
| Labeler Name | Larken Laboratories, Inc. |
| Substance Name | DEXAMETHASONE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-08-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA201270 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-08 |
| Marketing Category | ANDA |
| Application Number | ANDA201270 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-08 |
| Marketing Category | ANDA |
| Application Number | ANDA201270 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-08 |
| Marketing Category | ANDA |
| Application Number | ANDA201270 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-09-01 |
| Ingredient | Strength |
|---|---|
| DEXAMETHASONE | 1.5 mg/1 |
| SPL SET ID: | fcc75691-974e-4a67-b9d7-64dde72b5595 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68047-702 | Dexamethasone | Dexamethasone 1.5 mg |
| 70362-702 | Dxevo | Dexamethasone 1.5 mg |
| 70362-707 | Dxevo | Dexamethasone 1.5 mg |